🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The objective of this study is to assess the effect of repeated doses of it...
Status
Recruiting
Location
Acpru /Id# 282143
Start Date
2026-05-05
Trial ID
NCT07599761
Treatments Being Tested
The primary objective of the study is to evaluate the effect of itraconazol...
Status
Completed
Location
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Start Date
2020-06-10
Trial ID
NCT04423601
Treatments Being Tested
The primary objective of this study was to assess the effect of rifampicin ...
Status
Completed
Location
The First Affiliated Hospital of Bengbu Medical College
Start Date
2021-10-27
Trial ID
NCT06246695
Treatments Being Tested
The purpose of this study is to evaluate the effects of multiple doses of s...
Status
Completed
Location
Celerion
Start Date
2020-09-14
Trial ID
NCT04410094
Treatments Being Tested
Esophageal cancer, which has a low 5-year overall survival rate for all sta...
Status
Recruiting
Location
Dallas VA Medical Center
Start Date
2019-06-24
Trial ID
NCT04018872
Treatments Being Tested
This is an open-label, single-center, single-sequence study to evaluate the...
Status
Completed
Location
Taisho Pharmaceutical Co., Ltd selected site
Start Date
2020-10-13
Trial ID
NCT04557163
Treatments Being Tested
This study is designed to assess 1) the effect of multiple doses of itracon...
Status
Completed
Location
Celerion
Start Date
2019-10-18
Trial ID
NCT04142762
The purpose of this study is to see how single dose of cyclosporine and mul...
Status
Completed
Location
Pfizer Clinical Research Unit - New Haven
Start Date
2024-12-23
Trial ID
NCT06541678
Treatments Being Tested
This study is to assess the change of itraconazole, a strong CYP3A inhibito...
Status
Completed
Location
Acpru /Id# 271617
Start Date
2024-11-13
Trial ID
NCT06722430
Treatments Being Tested
This is a single-center, open, single-dose, self-controlled phase I clinica...
Status
Completed
Location
Shandong Provincial Hospital
Start Date
2023-09-21
Trial ID
NCT06024915
Treatments Being Tested